Immunization with Attenuated Pneumococcal Strains Provides Protection Against Pneumococcal Colonization in Humans

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2023 Sep 6

PMID 37672662

Authors

Ana Rita Narciso

Birgitta Henriques-Normark

Affiliations

Soon will be listed here.

References

Hanquet G, Krizova P, Valentiner-Branth P, Ladhani S, Nuorti J, Lepoutre A . Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination. Thorax. 2018; 74(5):473-482. PMC: 6484683. DOI: 10.1136/thoraxjnl-2018-211767. View

Ramos-Sevillano E, Ercoli G, Felgner P, de Assis R, Nakajima R, Goldblatt D . Preclinical Development of Virulence-attenuated Strains Able to Enhance Protective Immunity against Pneumococcal Infection. Am J Respir Crit Care Med. 2020; 203(8):1037-1041. PMC: 8048742. DOI: 10.1164/rccm.202011-4161LE. View

. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018; 18(11):1191-1210. PMC: 6202443. DOI: 10.1016/S1473-3099(18)30310-4. View

Naucler P, Galanis I, Morfeldt E, Darenberg J, Ortqvist A, Henriques-Normark B . Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations. Clin Infect Dis. 2017; 65(11):1780-1789. PMC: 5848315. DOI: 10.1093/cid/cix685. View

Ferreira D, Neill D, Bangert M, Gritzfeld J, Green N, Wright A . Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am J Respir Crit Care Med. 2013; 187(8):855-64. PMC: 3707375. DOI: 10.1164/rccm.201212-2277OC. View

Wilson R, Cohen J, Jose R, de Vogel C, Baxendale H, Brown J . Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses. Mucosal Immunol. 2014; 8(3):627-39. PMC: 4351900. DOI: 10.1038/mi.2014.95. View

Naucler P, Galanis I, Petropoulos A, Granath F, Morfeldt E, Ortqvist A . Chronic Disease and Immunosuppression Increase the Risk for Nonvaccine Serotype Pneumococcal Disease: A Nationwide Population-based Study. Clin Infect Dis. 2021; 74(8):1338-1349. PMC: 9049269. DOI: 10.1093/cid/ciab651. View

Moffitt K, Gierahn T, Lu Y, Gouveia P, Alderson M, Flechtner J . T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe. 2011; 9(2):158-65. PMC: 3061323. DOI: 10.1016/j.chom.2011.01.007. View

Brueggemann A, Jansen van Rensburg M, Shaw D, McCarthy N, Jolley K, Maiden M . Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance.... Lancet Digit Health. 2021; 3(6):e360-e370. PMC: 8166576. DOI: 10.1016/S2589-7500(21)00077-7. View

10.

Galanis I, Lindstrand A, Darenberg J, Browall S, Nannapaneni P, Sjostrom K . Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden. Eur Respir J. 2016; 47(4):1208-18. PMC: 4819883. DOI: 10.1183/13993003.01451-2015. View

11.

Hill H, Mitsi E, Nikolaou E, Blizard A, Pojar S, Howard A . A Randomized Controlled Clinical Trial of Nasal Immunization with Live Virulence Attenuated Strains Using Human Infection Challenge. Am J Respir Crit Care Med. 2023; 208(8):868-878. DOI: 10.1164/rccm.202302-0222OC. View

12.

Hanquet G, Krizova P, Dalby T, Ladhani S, Nuorti J, Danis K . Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe. Emerg Infect Dis. 2021; 28(1):137-138. PMC: 8714201. DOI: 10.3201/eid2801.210734. View